/biz/ - Business & Finance

>>17331984
>71.13% of the stock is owned by institutional investors.

They're just taking profits, just gotta wait until the positive earnings come out. Low price target is $22, high is $32. TMDX makes the only ex-vivo heart perfusion machine that's currently FDA approved. It's still waiting for approval for livers which is the next big catalyst for it to jump. That said, my long term outlook is that they will get bought out by United Therapeutics, just like Lung Bioengineering.